Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Vivanza Biosciences
Join Channel
Consolidated Standalone

Vivanza Biosciences

₹7.3 -0 | 0.3%

Market Cap ₹29 Cr.

Stock P/E 52.9

P/B 6.3

Current Price ₹7.3

Book Value ₹ 1.2

Face Value 1

52W High ₹15.2

Dividend Yield 0%

52W Low ₹ 5.7

Edit Ratio

Vivanza Biosciences Research see more...

Overview Inc. Year: 1982Industry: Trading

Vivanza Biosciences Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Vivanza Biosciences Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 2 6 2 1 6 8 9 8 7 4
Other Income 0 0 0 0 0 0 0 0 0 -0
Total Income 2 6 2 2 6 8 9 8 7 4
Total Expenditure 1 6 2 1 5 8 9 7 6 5
Operating Profit 0 0 0 0 1 0 1 0 0 -0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 -0 0 0 0 0 0 0 0 0
Profit Before Tax -0 -0 0 0 0 0 0 0 0 -0
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax -0 -0 0 0 0 -0 0 0 0 -0
Adjustments -0 0 -0 0 -0 -0 0 -0 0 0
Profit After Adjustments -0 -0 0 0 0 -0 0 0 0 -0
Adjusted Earnings Per Share -0 -0.1 0 0 0.1 -0 0.1 0.1 0.1 -0.1

Vivanza Biosciences Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 0 3 6 3 10 10 10 18 28
Other Income 0 0 0 0 1 1 1 0 0
Total Income 0 4 6 3 10 10 11 18 28
Total Expenditure 0 4 6 3 10 10 10 17 27
Operating Profit -0 -0 1 -0 0 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0
Profit Before Tax -0 -0 0 -0 -0 0 0 1 0
Provision for Tax 0 0 0 0 0 0 0 0 0
Profit After Tax -0 -0 0 -0 -0 0 0 1 0
Adjustments 0 0 0 0 0 0 0 0 0
Profit After Adjustments -0 -0 0 -0 -0 0 0 1 0
Adjusted Earnings Per Share -0.3 -0.1 0.1 -0.1 -0.1 0 0.1 0.1 0.2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 80% 22% 25% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -50% 4% 33% 27%
ROE Average 16% 9% 2% -31%
ROCE Average 11% 13% 9% 5%

Vivanza Biosciences Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 0 4 4 3 3 3 3 4
Minority's Interest 0 0 0 0 0 0 0 0
Borrowings 0 0 1 1 0 0 3 1
Other Non-Current Liabilities 0 0 0 0 0 -0 -0 -0
Total Current Liabilities 1 3 6 7 9 5 9 17
Total Liabilities 1 7 10 11 12 8 16 22
Fixed Assets 0 2 2 2 2 2 2 2
Other Non-Current Assets 1 1 1 1 1 1 1 1
Total Current Assets 0 4 7 8 9 5 12 20
Total Assets 1 7 10 11 12 8 16 22

Vivanza Biosciences Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 -3 -2 -3 -3 -3 0 0
Cash Flow from Operating Activities 0 -2 -0 1 3 -3 2 -1
Cash Flow from Investing Activities 0 2 0 0 0 -0 0 0
Cash Flow from Financing Activities 0 0 -1 -1 -3 2 -2 1
Net Cash Inflow / Outflow 0 0 -1 -0 0 -0 -0 0
Closing Cash & Cash Equivalent 0 -2 -3 -3 -3 -3 0 0

Vivanza Biosciences Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -0.32 -0.08 0.05 -0.11 -0.05 0.02 0.08 0.15
CEPS(Rs) -0.32 -0.08 0.05 -0.11 -0.05 0.02 0.09 0.15
DPS(Rs) 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0.13 0.88 0.93 0.82 0.77 0.79 0.87 1.02
Core EBITDA Margin(%) 0 -9.02 9.35 -0.75 -3.47 1.04 -0.52 3.8
EBIT Margin(%) 0 -7.71 9.37 -0.75 2.46 6.05 7.37 6.46
Pre Tax Margin(%) 0 -8.96 3.63 -16.58 -2.14 1.25 3.21 4.02
PAT Margin (%) 0 -8.96 3.19 -16.58 -2.14 0.76 3.2 3.36
Cash Profit Margin (%) 0 -8.96 3.19 -16.58 -2.14 0.86 3.27 3.37
ROA(%) -9.49 -7.99 2.37 -4.15 -1.75 0.72 2.77 3.15
ROE(%) -242.6 -17.54 5.66 -12.56 -6.46 2.41 10.01 15.78
ROCE(%) -11.38 -10.82 12.73 -0.4 5.74 17.11 12.25 10.91
Receivable days 0 265.59 215.42 739.09 232.09 236.05 247.26 208.25
Inventory Days 0 190.14 115.99 294.22 56.37 29.92 54.08 50.25
Payable days 0 154.92 244.01 813.9 271.47 239.43 176.75 166.22
PER(x) 0 0 136.35 0 0 693.43 226.47 125.67
Price/Book(x) 58.21 21.55 7.51 0 0 16.53 21.61 18.38
Dividend Yield(%) 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0 22.8 5.01 3.19 0.74 5.63 7.78 4.66
EV/Core EBITDA(x) -31.89 -295.56 53.51 -427.2 30.27 91.64 104.51 72.06
Net Sales Growth(%) 0 0 85.35 -58.73 261.94 2.78 5.18 71.22
EBIT Growth(%) 0 -344.6 325.17 -103.29 1291.94 152.62 28.26 49.97
PAT Growth(%) 0 -416.18 165.94 -314.69 53.34 136.62 342.02 79.67
EPS Growth(%) 0 75.74 165.94 -314.69 53.34 136.62 342.29 79.59
Debt/Equity(x) 20.3 0.25 0.35 0.45 0.13 0.11 1.58 1.95
Current Ratio(x) 0.07 1.25 1.21 1.06 1.01 0.95 1.31 1.15
Quick Ratio(x) 0.07 0.7 0.82 0.78 0.9 0.82 1.06 1.01
Interest Cover(x) -1070.61 -6.17 1.63 -0.05 0.53 1.26 1.77 2.65
Total Debt/Mcap(x) 0.35 0.02 0.05 0 0 0.01 0.07 0.11

Vivanza Biosciences Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 47.8 47.8 47.8 47.8 47.8 47.8 47.8 47.29 44.9 43.24
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 52.2 52.2 52.2 52.2 52.2 52.2 52.2 52.71 55.1 56.76
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 176.75 to 166.22days.
  • Company has reduced debt.

Cons

  • Promoter holding is low: 43.24%.
  • Company has a low return on equity of 9% over the last 3 years.
  • Stock is trading at 6.3 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Vivanza Biosciences News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!